El Chaer F, Perissinotti AJ, Loghavi S, Zeidan AM, et al. Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time? Leukemia 2024 Nov 5. doi: 10.1038/s41375-024-02458.
PMID: 39496917